[Clinical studies of Magurlit granulates].
The possibilities of dissolving by means of medication uric acid and uric acid-calcium oxalate calculi are discussed. The biochemical causes of uric acid lithogenesis was studied. Due to successful pharmacotherapy the number of operations has greatly diminished in recent years. On the basis of experience gained with various citrate mixtures the authors claim that Magurlit is the most advantageous litholytic drug. Due to its magnesium and vitamin B6 content it is also suitable for the dissolution of uric acid calculi containing calcium oxalate in diffuse distribution, i.e. for the prevention of the development of stones of this type.
D000368:Aged; D002129:Calcium Oxalate / Q000378:metabolism; D002951:Citrates / Q000627:therapeutic use*; D019343:Citric Acid; D004338:Drug Combinations / Q000627:therapeutic use; D006801:Humans; D007669:Kidney Calculi / Q000188:drug therapy* / Q000378:metabolism / Q000517:prevention & control; D008875:Middle Aged; D011736:Pyridoxine / Q000627:therapeutic use*; D014527:Uric Acid / Q000378:metabolism
D002951:Citrates; D004338:Drug Combinations; D002129:Calcium Oxalate; D014527:Uric Acid; D019343:Citric Acid; C008309:magnesium citrate, potassium citrate, pyridoxine HCl, sodium citrate drug combination; D011736:Pyridoxine
Klinische Untersuchung des Magurlit-Granulates.